Characteristics of fusion gene expression in acute lymphoblastic leukemia

Xian-Qi HUANG; Ya-Ni LIN; En-Bin LIU; Fei XING; Zhe WANG; Xue-Jing CHEN; Long CHEN; Jing-Ting MA; Ying-Chang MI; Kun RU.
Chinese Journal of Pathology ; (12): 307-313, 2022.
Artículo en Zh | WPRIM | ID: wpr-935531

Documentos relacionados

  1. [Characteristics of fusion gene expression in acute lymphoblastic leukemia].
  2. Detection of <i>RAS</i> gene mutation and its clinical significance in children with acute lymphoblastic leukemia.
  3. N-terminus DUX4-immunohistochemistry is a reliable methodology for the diagnosis of DUX4-fused B-lymphoblastic leukemia/lymphoma (N-terminus DUX4 IHC for DUX4-fused B-ALL).
  4. A surrogate molecular approach for the detection of Philadelphia chromosome-like B-acute lymphoblastic leukemia.
  5. BCL6 inhibition ameliorates resistance to ruxolitinib in <i>CRLF2</i>-rearranged acute lymphoblastic leukemia.
  6. Dysregulation of BCL-2 family proteins by leukemia fusion genes.
  7. Metabolic reprogramming in childhood acute lymphoblastic leukemia.
  8. Concurrent CDX2 cis-deregulation and UBTF::ATXN7L3 fusion define a novel high-risk subtype of B-cell ALL.
  9. XBP1 promotes NRAS<sup>G12D</sup> pre-B acute lymphoblastic leukaemia through IL-7 receptor signalling and provides a therapeutic vulnerability for oncogenic RAS.
  10. Genomic and proteomic characterization of Philadelphia-like B-lineage acute lymphoblastic leukemia: A report of Indian patients.